Lazard Asset Management
ALPN

Lazard Asset Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Lazard Asset Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,518
Closed -$298K – 2477
2024
Q1 		$298K Buy
7,518
+2,110
+39% +$62.3K ﹤0.01% 1181
2023
Q4 		$103K Buy
+5,408
New +$75.1K ﹤0.01% 1648
2022
Q3 		– Sell
-4,617
Closed -$39K – 2599
2022
Q2 		$39K Buy
+4,617
New +$39.8K ﹤0.01% 1920

Lazard Asset Management's ALPN Position: Q2 2024 in Review

Lazard Asset Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 7,518 shares — an estimated $298K sold.

Lazard Asset Management first reported a position in ALPN in Q2 2022 and held it in 3 quarters. The position peaked at $298K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Lazard Asset Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Lazard Asset Management sold 7,518 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $298K.
  • Lazard Asset Management first reported a position in Alpine Immune Sciences Inc in Q2 2022 and held it in 3 quarters.
  • Lazard Asset Management's Alpine Immune Sciences Inc position peaked at $298K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Lazard Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.